The Labile Side of Iron Supplementation in CKD

The Labile Side of Iron Supplementation in CKD

Item
http://www.wikidata.org/entity/Q38496987
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st CenturyEfficiency of Original versus Generic Intravenous Iron Formulations in Patients on HaemodialysisComparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patientsThe Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients.Neurocognitive Function Is Associated With Serum Iron Status in Early Adolescents.Investigational therapies for renal disease-induced anemia.Hydrogen peroxide signals E. coli phagocytosis by human polymorphonuclear cells; up-stream and down-stream pathway.Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.Sustained plasma hepcidin suppression and iron elevation by Anticalin-derived hepcidin antagonist in cynomolgus monkey.Iron-induced calcification in human aortic vascular smooth muscle cells through interleukin-24 (IL-24), with/without TNF-alpha.Anticalin® Proteins as Therapeutic Agents in Human Diseases.Intravenous Irons: From Basic Science to Clinical Practice
P2860

The Labile Side of Iron Supplementation in CKD

Item
http://www.wikidata.org/entity/Q38496987
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Labile Side of Iron Supplementation in CKD
@en
type
label
The Labile Side of Iron Supplementation in CKD
@en
prefLabel
The Labile Side of Iron Supplementation in CKD
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
The Labile Side of Iron Supplementation in CKD
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932